Invezz

Eli Lilly cuts insulin-related out of pocket expense for diabetes patients in the U.S

Eli Lilly cuts insulin-related out of pocket expense for diabetes patients in the U.S
Health & pharma
Wajeeh Khan
Author
Wajeeh K.
Apr 07, 2020, 09:43 AM
  • Eli Lilly caps the out of pocket expense for insulin at £27.50/month for U.S patients.
  • U.S drugmaker's co-pay scheme will not cover the patients enrolled in government insurance.
  • Trump administration to reduce the out of pocket cost for insulin to £27.50/month.

Eli Lilly & Company (NYSE:LLY) announced a cap of £27.50/month on the out of pocket expense for insulin on Tuesday. The company said that it wishes to help the U.S patients that are facing financial challenges ascribed to the ongoing COVID-19 pandemic.

Aug 27, 2026, 23:54 PM
Samsung stock retreat again: why a massive payout isn’t enough for investors
Stock market

Samsung stock retreat again: why a massive payout isn’t enough for investors

Aug 27, 2026, 23:14 PM
Why Marvell stock is slipping despite a classic ‘beat and raise’
Stock market

Why Marvell stock is slipping despite a classic ‘beat and raise’

Aug 27, 2026, 16:28 PM
Nasdaq closes 411 points higher as Nvidia rally boosts tech stocks
Stock market

Nasdaq closes 411 points higher as Nvidia rally boosts tech stocks

Aug 27, 2026, 15:39 PM
Evening digest: Bitcoin hits $80K, oil and gold prices rise
Stock market

Evening digest: Bitcoin hits $80K, oil and gold prices rise

Aug 27, 2026, 14:39 PM
Novo Nordisk stock falls as Deutsche Bank downgrades shares to sell
Stock market

Novo Nordisk stock falls as Deutsche Bank downgrades shares to sell

No results found

Loading articles...

Failed to load articles. Please try again.